Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AGNCB - AGNC Investment Corp. Deposit Repr 1/1000th 7 3/4 % Cum Red Perp Pfd Class B


Previous close
25.21
25.210   100.000%

Share volume: 0
Last Updated: Mon 25 Nov 2019 10:00:00 PM CET
Real Estate Investment Trusts: 0%

PREVIOUS CLOSE
CHG
CHG%

N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
60%
Profitability 25%
Dept financing 25%
Liquidity 75%
Performance 100%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$25.21
P/E Ratio 
N/A
DAY RANGE
$25.21 - $25.21
EPS 
$0.00
52 WEEK RANGE
$24.99 - $26.02
52 WEEK CHANGE
-$1.18
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
$0.4844
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$37,715
AVERAGE 30 VOLUME 
$42,251
Company detail
CEO: Gary D. Kain
Region: US
Website: http://www.agnc.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Real Estate Investment Trusts
Sector: Finance

AGNC Investment Corp. operates as a real estate investment trust. It primarily invests in agency residential mortgage-backed securities on a leveraged basis. The firm's investments consist of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a United States Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, and by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities where repayment of principal and interest is not guaranteed by a GSE or U.S. Government agency. The company was founded on January 7, 2008 and is headquartered in Bethesda, MD.

Recent news